What is the frequency of monitoring and evaluating the established clinical goals by the cancer committee according to Standard 1.5?

The correct response is that the cancer committee is required to monitor and evaluate the established clinical goals twice within the same calendar year. This frequency ensures that the committee can actively track progress and outcomes related to the clinical goals, allowing for timely adjustments or interventions as necessary. Monitoring and evaluating goals more frequently than once a year enables the committee to maintain a dynamic approach to quality improvement, ensuring that any necessary changes in practice can be implemented quickly in response to the data collected.

Additionally, by assessing the goals twice a year, the committee is positioned to engage in more detailed discussions about trends, challenges, and successes that may arise throughout the year. This approach fosters accountability and encourages ongoing quality improvement initiatives, making it a best practice in cancer care.